Loading...
You are viewing a DELETED record.
This record information is displayed for reference purpose only and should be not used.
This document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Living Modified Organism
(LMO)
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
Proteqflu - equine influenza vaccine
EN
Strains vCP2242 and vCP1533
No
-
,Organization:Merial ()Private sector (business and industry)
, FrancePhone: +33 472 72 3000,Fax:Email:Website: http://fr.merial.com,
"Proteqflu" is a vaccine made from recombinant canary pox virus modified with haemagglutinin gene from Equine Influenza. This LMO is used to vaccinate horses against Equine Influenza.
After inoculation, the viruses do not multiply in the horse but express the protective proteins. As a consequence, these components induce immunity against equine influenza virus (H3N8).
EN
After inoculation, the viruses do not multiply in the horse but express the protective proteins. As a consequence, these components induce immunity against equine influenza virus (H3N8).
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
-
BCH-ORGA-SCBD-45008-6 Organism Canarypox virus (CNPV)Viruses
EN
-
Proteqflu-Te - equine influenza vaccine| Merial | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
pJT006
EN
- Other (Homologous Recombination)
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
-
BCH-GENE-SCBD-45883-4 Hemagglutinin gene | Influenza A virus (Influenza, Flu, Avian flu, Human flu, Swine influenza, Equine influenza, Bird flu)Protein coding sequence | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-GENE-SCBD-103890-2 H6 Gene Promoter | Vaccinia virus (Poxvirus, Smallpox vaccine, VACV, VV, Vaccinia)Promoter
-
BCH-GENE-SCBD-103891-1 C5 right flanking arm | Canarypox virus (CNPV)Plasmid Vector
-
BCH-GENE-SCBD-103892-1 C5 left flanking arm | Canarypox virus (CNPV)Plasmid Vector
The following strains of Influenza viruses were used as donor organisms:
Influenza A/equine-2/Ohio/03[H3N8]Canarypox virus (vCP2242 - American strain)and Influenza A/equi-2/Newmarket/2/93 [H3N8] recombinant Canarypox virus (vCP1533 - European strain).
EN
Influenza A/equine-2/Ohio/03[H3N8]Canarypox virus (vCP2242 - American strain)and Influenza A/equi-2/Newmarket/2/93 [H3N8] recombinant Canarypox virus (vCP1533 - European strain).
EN
- Vaccine
EN
EN
| Record type | Field | Record(s) | |||||
|---|---|---|---|---|---|---|---|
|
|||||||
|
|||||||
|
|||||||
